Anti-inflammatory treatment and risk for depression after first-time stroke in a cohort of 147 487 Danish patients

被引:35
作者
Wium-Andersen, Ida Kim [1 ,2 ,4 ,5 ]
Wium-Andersen, Marie Kim [2 ,3 ,4 ,5 ]
Jorgensen, Martin Balslev [4 ,5 ]
Osler, Merete [2 ,6 ]
机构
[1] Psychiat Ctr Ballerup, Maglevaenget 2, DK-2750 Ballerup, Denmark
[2] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark
[3] Psychiat Ctr Frederiksberg, Frederiksberg, Denmark
[4] Univ Copenhagen, Psychiat Ctr Copenhagen, Dept O, Copenhagen, Denmark
[5] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark
[6] Univ Copenhagen, Sect Social Med, Dept Publ Hlth, Copenhagen, Denmark
来源
JOURNAL OF PSYCHIATRY & NEUROSCIENCE | 2017年 / 42卷 / 05期
关键词
POSTSTROKE DEPRESSION; ISCHEMIC-STROKE; MAJOR DEPRESSION; DOUBLE-BLIND; STATIN USE; CYCLOOXYGENASE-2; METAANALYSIS; HYPOTHESIS; MORTALITY; SYMPTOMS;
D O I
10.1503/jpn160244
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Depression is a common complication after stroke, and inflammation may be a pathophysiological mechanism. This study examines whether anti-inflammatory treatment with acetylsalicylic acid (ASA), nonsteroid anti-inflammatory drugs (NSAIDs) or statins influence the risk of depression after stroke. Methods: A register-based cohort including all patients admitted to hospital with a first-time stroke from Jan. 1, 2001, through Dec. 31, 2011, and a nonstroke population with a similar age and sex distribution was followed for depression until Dec. 31, 2014. Depression was defined as having a hospital contact with depression or having filled prescriptions for antidepressant medication. The associations between redeemed prescriptions of ASA, NSAIDs or statins with early- (<= 1 year after stroke or study entry) and late-onset (> 1 year after stroke or study entry) depression were analyzed using Cox proportional hazard regression. Results: We identified 147 487 patients with first-time stroke and 160 235 individuals without stroke for inclusion in our study. Redeemed prescriptions of ASA, NSAIDs or statins after stroke decreased the risk for early-onset depression, especially in patients with ischemic or severe stroke. Patients who received a combination of anti-inflammatory treatments had the lowest risk for early-onset depression. On the other hand, use of ASA or NSAIDs 1 year after stroke increased the risk for late-onset depression, whereas statin use was associated with a tendency toward a decreased risk. Limitations: The study used prescription of antidepressant medication as a proxy measure for depression and did not include anti-inflammatory drugs bought over the counter. Conclusion: Anti-inflammatory treatment is associated with a lower risk for depression shortly after stroke but a higher risk for late depression. This suggests that inflammation contributes differently to the development of depression after stroke depending on the time of onset.
引用
收藏
页码:320 / 330
页数:11
相关论文
共 32 条
  • [1] Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
    Abbasi, Seyed-Hesameddin
    Hosseini, Fahimeh
    Modabbernia, Amirhossein
    Ashrafi, Mandana
    Akhondzadeh, Shahin
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2012, 141 (2-3) : 308 - 314
  • [2] Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2
    Aid, Saba
    Langenbach, Robert
    Bosetti, Francesca
    [J]. JOURNAL OF NEUROINFLAMMATION, 2008, 5 (1)
  • [3] Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis
    Ayerbe, Luis
    Ayis, Salma
    Wolfe, Charles D. A.
    Rudd, Anthony G.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (01) : 14 - 21
  • [4] Validity and reliability of estimating the Scandinavian Stroke Scale score from medical records
    Barber, M
    Fail, M
    Shields, M
    Stott, DJ
    Langhorne, P
    [J]. CEREBROVASCULAR DISEASES, 2004, 17 (2-3) : 224 - 227
  • [5] Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli
    Blais, V
    Turrin, NP
    Rivest, S
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 95 (06) : 1563 - 1574
  • [6] TSPO imaging in stroke: from animal models to human subjects
    Boutin H.
    Pinborg L.H.
    [J]. Clinical and Translational Imaging, 2015, 3 (6) : 423 - 435
  • [7] Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression
    Brouwers, Corline
    Christensen, Stefan B.
    Damen, Nikki L.
    Denollet, Johan
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    Pedersen, Susanne S.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 203 : 867 - 873
  • [8] C-reactive protein in ischemic stroke - An independent prognostic factor
    Di Napoli, M
    Papa, F
    Bocola, V
    [J]. STROKE, 2001, 32 (04) : 917 - 924
  • [9] Systemic inflammation as a therapeutic target in acute ischemic stroke
    Dziedzic, Tomasz
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (05) : 523 - 531
  • [10] Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H2 receptor antagonists in community-dwelling older persons -: Cross-sectional analysis of a population-based cohort
    Feng, Liang
    Tan, Chay-Hom
    Merchant, Reshma A.
    Ng, Tze-Pin
    [J]. DRUGS & AGING, 2008, 25 (09) : 795 - 805